Viewing StudyNCT03666988



Ignite Creation Date: 2024-05-06 @ 12:03 PM
Last Modification Date: 2024-10-26 @ 12:53 PM
Study NCT ID: NCT03666988
Status: TERMINATED
Last Update Posted: 2022-05-20
First Post: 2018-09-10

Brief Title: First Time in Humans FTIH Study of GSK3368715 in Participants With Solid Tumors and Diffuse Large B-cell Lymphoma DLBCL
Sponsor: GlaxoSmithKline
Organization: GlaxoSmithKline

Conditions & Keywords Data

Conditions:
Name
Neoplasms
Keywords:
Name View
Diffuse Large B-Cell Lymphoma View
Dose-escalation View
First time in humans View
Solid tumors View
GSK3368715 View